Literature DB >> 19083039

Highlights of the hotline sessions presented at the scientific sessions 2008 of the American Heart Association.

Helge Möllmann1, Holger Nef, Michael Böhm, Ulrich Laufs.   

Abstract

Summaries and commentaries on trials presented at the hotline sessions of the scientific sessions 2008 of the American Heart Association in New Orleans have been generated from the oral presentations and the webcasts of the American Heart Association. The following papers are discussed: APPROACH, ATLAS, BACH, BICC, HF-ACTION, I-PRESERVE, JPAD, JUPITER, Mass-DAC, Physicians' Health Study II, SEARCH, tailored clopidogrel loading to prevent stent thrombosis, and TIMACS.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19083039     DOI： 10.1007/s00392-008-0742-x

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN： 1861-0684            Impact factor:   5.460


  6 in total

Review 1.  Low density lipoprotein cholesterol, statins and cardiovascular events: a meta-analysis.

Authors:  Bernd Genser; Winfried März
Journal:  Clin Res Cardiol       Date:  2006-06-20       Impact factor: 5.460

2.  Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial.

Authors:  Howard D Sesso; Julie E Buring; William G Christen; Tobias Kurth; Charlene Belanger; Jean MacFadyen; Vadim Bubes; JoAnn E Manson; Robert J Glynn; J Michael Gaziano
Journal:  JAMA       Date:  2008-11-09       Impact factor: 56.272

3.  Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial.

Authors:  Hisao Ogawa; Masafumi Nakayama; Takeshi Morimoto; Shiro Uemura; Masao Kanauchi; Naofumi Doi; Hideaki Jinnouchi; Seigo Sugiyama; Yoshihiko Saito
Journal:  JAMA       Date:  2008-11-09       Impact factor: 56.272

4.  Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

Authors:  Paul M Ridker; Eleanor Danielson; Francisco A H Fonseca; Jacques Genest; Antonio M Gotto; John J P Kastelein; Wolfgang Koenig; Peter Libby; Alberto J Lorenzatti; Jean G MacFadyen; Børge G Nordestgaard; James Shepherd; James T Willerson; Robert J Glynn
Journal:  N Engl J Med       Date:  2008-11-09       Impact factor: 91.245

5.  Drug-eluting or bare-metal stenting in patients with diabetes mellitus: results from the Massachusetts Data Analysis Center Registry.

Authors:  Pallav Garg; Sharon-Lise T Normand; Treacy S Silbaugh; Robert E Wolf; Katya Zelevinsky; Ann Lovett; Manu R Varma; Zheng Zhou; Laura Mauri
Journal:  Circulation       Date:  2008-11-10       Impact factor: 29.690

6.  Irbesartan in patients with heart failure and preserved ejection fraction.

Authors:  Barry M Massie; Peter E Carson; John J McMurray; Michel Komajda; Robert McKelvie; Michael R Zile; Susan Anderson; Mark Donovan; Erik Iverson; Christoph Staiger; Agata Ptaszynska
Journal:  N Engl J Med       Date:  2008-11-11       Impact factor: 91.245
  6 in total
  4 in total

1.  Frequency of heparin/platelet factor 4-dependent platelet antibodies in patients undergoing angioplasty and stenting for cardiovascular disease and their role for on-clopidogrel platelet reactivity.

Authors:  Thomas Gremmel; Karin Frühwirth; Christoph W Kopp; Alexandra Kaider; Sabine Steiner; Tamam Bakchoul; Ulrich J H Sachs; Renate Koppensteiner; Simon Panzer
Journal:  Clin Res Cardiol       Date:  2012-01-11       Impact factor: 5.460

2.  Late-breaking clinical trials presented at the American Heart Association Congress in Chicago 2010.

Authors:  Christoph Gensch; Uta Hoppe; Michael Böhm; Ulrich Laufs
Journal:  Clin Res Cardiol       Date:  2010-12-23       Impact factor: 5.460

3.  Hotlines and clinical trial updates presented at the European Society of Cardiology Meeting 2009: data from RE-LY, PLATO, MADIT-CRT, PROTECT, SYNTAX, TRITON and more.

Authors:  S H Schirmer; A M van der Laan; M Böhm; F Mahfoud
Journal:  Clin Res Cardiol       Date:  2009-11       Impact factor: 5.460

4.  Hotline sessions presented at the American College of Cardiology Congress 2009.

Authors:  Lars S Maier; Magnus Baumhäkel; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2009-05-09       Impact factor: 5.460
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.